efaproxiral inn analogue cholesterol drug bezafibrate developed treatment depression traumatic brain injury ischemia stroke myocardial infarction diabetes hypoxia sickle cell disease hypercholesterolemia radio chemical derivative propanoic acid one use efaproxiral increase efficacy certain chemotherapy drugs reduced efficacy hypoxic tumours thus made effective increased offloading oxygen tumour benefit seen efaproxiral phase iii clinical increased oxygenation tissues could theoretically also produce enhanced exercise capacity feline rat canine models approximately min immediately high dosage min intravenous led world antidoping agency categorise efaproxiral prohibited method artificially enhance uptake transport delivery existing evidence efaproxiral effectively enhance performance efaproxiral absorbed via transdermal rectal inhalation gastrointestinal routes though plasma concentrations great enough alter oxygenhaemoglobin dissociation efaproxiral explicitly excluded world antidoping agency list prohibited substances explicitly included prohibited methods section forbidden procedure alter oxygenhaemoglobin dissociation curve order allosterically modify httpsenwikipediaorgwikiefaproxiral